FSB Premier Wealth Management’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
DCM
GIPM
GIP
FSB Premier Wealth Management's OPRX Position: Q1 2022 in Review
FSB Premier Wealth Management sold out of OptimizeRx (OPRX) in Q1 2022, closing a stake of 332 shares — an estimated $20K sold.
FSB Premier Wealth Management first reported a position in OPRX in Q4 2021 and held it in 1 quarter. The position peaked at $20K in Q4 2021. 153 funds tracked by Wall St. Rank hold OPRX as of Q1 2022.
- FSB Premier Wealth Management reported no remaining OptimizeRx position as of Q1 2022 after selling out during the quarter.
- FSB Premier Wealth Management sold 332 OptimizeRx shares in Q1 2022, an estimated $20K.
- FSB Premier Wealth Management first reported a position in OptimizeRx in Q4 2021 and held it in 1 quarter.
- FSB Premier Wealth Management's OptimizeRx position peaked at $20K in Q4 2021.
- 153 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2022.
Based on FSB Premier Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.